STOCK TITAN

Aldeyra Therapeutics (NASDAQ: ALDX) leases new Concord headquarters space

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Aldeyra Therapeutics, Inc. executed an office lease with Bradford Street, L.L.C. for approximately 4,067 square feet at 23 Bradford Street, Concord, Massachusetts, to serve as its corporate headquarters.

The lease starts on September 1, 2026 and runs through September 30, 2029. It provides for an initial monthly base rent of $12,201.00, which increases annually, plus operating expenses, taxes, and other fees. Aldeyra will post a $50,000.00 security deposit.

Positive

  • None.

Negative

  • None.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Leased area 4,067 square feet Office space at 23 Bradford Street, Concord, Massachusetts
Monthly base rent $12,201.00 Initial monthly base rent under the office lease
Security deposit $50,000.00 Initial security deposit required under the lease
Lease commencement date September 1, 2026 Start date of the office lease term
Lease end date September 30, 2029 Scheduled end of the lease term
Base Rent financial
"provides for a monthly base rent of $12,201.00, increasing each year"
The fixed minimum rent a tenant pays under a lease before any extra charges or variable fees; think of it as the subscription price for a space, separate from add‑ons like utilities, maintenance, or a share of property taxes. Investors watch base rent because it sets the predictable, recurring income stream that determines a property's immediate cash flow and helps value the asset, while extras and escalations affect total returns and risk.
security deposit financial
"The Company will post an initial security deposit in the amount of $50,000.00"
operating expenses financial
"required to pay Bradford Street certain operating expenses, taxes, and other fees"
Operating expenses are the routine costs a company pays to keep its business running day to day — things like salaries, rent, utilities, office supplies, and marketing. Investors watch them because they reduce the profit available to shareholders and reveal how efficiently a company runs; lower or well-controlled operating expenses (relative to revenue) are like trimming household bills to improve savings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What new lease did Aldeyra Therapeutics (ALDX) sign for its headquarters?

Aldeyra signed an office lease with Bradford Street, L.L.C. for 4,067 square feet at 23 Bradford Street, Concord, Massachusetts, to be used as its corporate headquarters. The lease runs from September 1, 2026 through September 30, 2029 and includes escalating rent.

What is the monthly base rent in Aldeyra Therapeutics (ALDX)’s new HQ lease?

The lease sets an initial monthly base rent of $12,201.00. This base rent increases each year as specified in the lease, and Aldeyra must also pay operating expenses, taxes, and other fees to the landlord, Bradford Street, L.L.C.

How long is the term of Aldeyra Therapeutics (ALDX)’s new office lease?

The lease term runs from September 1, 2026 to September 30, 2029. During this period Aldeyra will occupy about 4,067 square feet at 23 Bradford Street, Concord, Massachusetts, using the premises as its corporate headquarters.

What upfront security deposit is Aldeyra Therapeutics (ALDX) required to post?

Aldeyra is required to post an initial security deposit of $50,000.00. This deposit supports its obligations under the office lease for the Concord, Massachusetts headquarters space, alongside the base rent and responsibility for operating expenses, taxes, and other fees.

What additional costs beyond base rent does Aldeyra Therapeutics (ALDX) owe under the new lease?

In addition to the initial monthly base rent of $12,201.00, Aldeyra must pay operating expenses, taxes, and other fees under the lease terms. The agreement also includes customary covenants covering occupancy, maintenance, and care of the premises.
false000134123500013412352026-07-282026-07-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 28, 2026

ALDEYRA THERAPEUTICS, INC.

(Exact name of Registrant as specified in its charter)

 

 

 

 

 

Delaware

001-36332

20-1968197

(State or other jurisdiction

of incorporation)

(Commission

File No.)

(IRS Employer

Identification No.)

131 Hartwell Avenue, Suite 320

Lexington, MA 02421

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (781) 761-4904

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


Securities registered pursuant to Section 12(b) of the Act:

 

 

 

 

 

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, $0.001 par value per share

ALDX

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


 

 

Item 1.01.

Entry into a Material Definitive Agreement.

On July 28, 2026, Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) executed a lease agreement (the “Office Lease”) with Bradford Street, L.L.C. (“Bradford Street”) for approximately 4,067 square feet of office space located at 23 Bradford Street, Concord, Massachusetts (the “Premises”). The Office Lease commences on September 1, 2026 and the term with respect to the Premises shall be for a period ending on September 30, 2029. The Company intends to use the Premises as its corporate headquarters. The Office Lease provides for a monthly base rent of $12,201.00, increasing each year as indicated in the Office Lease (the “Base Rent”). In addition to the Base Rent, the Company is required to pay Bradford Street certain operating expenses, taxes, and other fees in accordance with the terms of the Office Lease. The Office Lease contains customary representations and covenants regarding occupancy, maintenance, and care of the Premises. The Company will post an initial security deposit in the amount of $50,000.00.

The foregoing description of the Office Lease does not purport to be complete and is qualified in its entirety by the full text of the Office Lease, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

No.

Description

10.1

Lease Agreement by and between Bradford Street, L.L.C. and Aldeyra Therapeutics, Inc.

 

 


 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ALDEYRA THERAPEUTICS, INC.

 

 

By:

/s/ Todd C. Brady

Name:

Todd C. Brady M.D., Ph.D.

Title:

Chief Executive Officer

Dated July 30, 2026


Filing Exhibits & Attachments

2 documents